Norplant-associated major depression and panic disorder

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Norplant is a long-acting subdermal implant system that is widely used for contraception. The implant releases a continuous dose of levonorgestrel, a synthetic progestin. Although oral contraceptives are associated with depression and panic disorder, no cases have been reported of psychiatric disorders secondary to the use of Norplant. Method: Two women, aged 18 and 29 years, are described who developed major depression and panic disorder while using the Norplant system. Results: These women who had no prior psychiatric history developed major depression and panic disorder 1 to 2 months after insertion of Norplant system capsules. The symptoms worsened over the course of a year. Following removal of Norplant, the symptoms of depression and anxiety resolved within 1 month. Conclusion: The progesterone content of oral contraceptives has been linked to major depression and panic disorder. Since Norplant is a progestin-only preparation, it is likely that some women will develop these disorders. These cases illustrate the importance of careful follow-up for adolescents and adults who select Norplant for contraception. Patients should be informed about the possible occurrence of psychiatric disorders. When evaluating new onset of depression and panic disorder in adolescent and adult women, it is important to inquire about Norplant insertion.

Original languageEnglish (US)
Pages (from-to)478-480
Number of pages3
JournalJournal of Clinical Psychiatry
Volume55
Issue number11
StatePublished - 1994

Fingerprint

Levonorgestrel
Panic Disorder
Depression
Psychiatry
Oral Contraceptives
Contraception
Progesterone Congeners
Progestins
Capsules
Progesterone
Anxiety

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Norplant-associated major depression and panic disorder. / Wagner, Karen; Berenson, Abbey.

In: Journal of Clinical Psychiatry, Vol. 55, No. 11, 1994, p. 478-480.

Research output: Contribution to journalArticle

@article{a3c1576cf2f5442f9a61094513b8d161,
title = "Norplant-associated major depression and panic disorder",
abstract = "Background: Norplant is a long-acting subdermal implant system that is widely used for contraception. The implant releases a continuous dose of levonorgestrel, a synthetic progestin. Although oral contraceptives are associated with depression and panic disorder, no cases have been reported of psychiatric disorders secondary to the use of Norplant. Method: Two women, aged 18 and 29 years, are described who developed major depression and panic disorder while using the Norplant system. Results: These women who had no prior psychiatric history developed major depression and panic disorder 1 to 2 months after insertion of Norplant system capsules. The symptoms worsened over the course of a year. Following removal of Norplant, the symptoms of depression and anxiety resolved within 1 month. Conclusion: The progesterone content of oral contraceptives has been linked to major depression and panic disorder. Since Norplant is a progestin-only preparation, it is likely that some women will develop these disorders. These cases illustrate the importance of careful follow-up for adolescents and adults who select Norplant for contraception. Patients should be informed about the possible occurrence of psychiatric disorders. When evaluating new onset of depression and panic disorder in adolescent and adult women, it is important to inquire about Norplant insertion.",
author = "Karen Wagner and Abbey Berenson",
year = "1994",
language = "English (US)",
volume = "55",
pages = "478--480",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "11",

}

TY - JOUR

T1 - Norplant-associated major depression and panic disorder

AU - Wagner, Karen

AU - Berenson, Abbey

PY - 1994

Y1 - 1994

N2 - Background: Norplant is a long-acting subdermal implant system that is widely used for contraception. The implant releases a continuous dose of levonorgestrel, a synthetic progestin. Although oral contraceptives are associated with depression and panic disorder, no cases have been reported of psychiatric disorders secondary to the use of Norplant. Method: Two women, aged 18 and 29 years, are described who developed major depression and panic disorder while using the Norplant system. Results: These women who had no prior psychiatric history developed major depression and panic disorder 1 to 2 months after insertion of Norplant system capsules. The symptoms worsened over the course of a year. Following removal of Norplant, the symptoms of depression and anxiety resolved within 1 month. Conclusion: The progesterone content of oral contraceptives has been linked to major depression and panic disorder. Since Norplant is a progestin-only preparation, it is likely that some women will develop these disorders. These cases illustrate the importance of careful follow-up for adolescents and adults who select Norplant for contraception. Patients should be informed about the possible occurrence of psychiatric disorders. When evaluating new onset of depression and panic disorder in adolescent and adult women, it is important to inquire about Norplant insertion.

AB - Background: Norplant is a long-acting subdermal implant system that is widely used for contraception. The implant releases a continuous dose of levonorgestrel, a synthetic progestin. Although oral contraceptives are associated with depression and panic disorder, no cases have been reported of psychiatric disorders secondary to the use of Norplant. Method: Two women, aged 18 and 29 years, are described who developed major depression and panic disorder while using the Norplant system. Results: These women who had no prior psychiatric history developed major depression and panic disorder 1 to 2 months after insertion of Norplant system capsules. The symptoms worsened over the course of a year. Following removal of Norplant, the symptoms of depression and anxiety resolved within 1 month. Conclusion: The progesterone content of oral contraceptives has been linked to major depression and panic disorder. Since Norplant is a progestin-only preparation, it is likely that some women will develop these disorders. These cases illustrate the importance of careful follow-up for adolescents and adults who select Norplant for contraception. Patients should be informed about the possible occurrence of psychiatric disorders. When evaluating new onset of depression and panic disorder in adolescent and adult women, it is important to inquire about Norplant insertion.

UR - http://www.scopus.com/inward/record.url?scp=0028580526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028580526&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 478

EP - 480

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 11

ER -